Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer

M. D. Galsky; E. J. Small; W. K. Oh; I. Chen; D. C. Smith; A. D. Colevas; L. Martone; T. Curley; A. Delacruz; H. I. Scher; W. K. Kelly; Donald L. Trump

doi:10.1016/j.urolonc.2005.06.016

Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer

M. D. Galsky, E. J. Small, W. K. Oh, I. Chen, D. C. Smith, A. D. Colevas, L. Martone, T. Curley, A. Delacruz, H. I. Scher, W. K. Kelly, Donald L. Trump

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	378
Number of pages	1
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	23
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2005.06.016
State	Published - 2005
Externally published	Yes

Access to Document

10.1016/j.urolonc.2005.06.016

Cite this

Galsky, M. D., Small, E. J., Oh, W. K., Chen, I., Smith, D. C., Colevas, A. D., Martone, L., Curley, T., Delacruz, A., Scher, H. I., Kelly, W. K., & Trump, D. L. (2005). Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer. Urologic Oncology: Seminars and Original Investigations, 23(5), 378. https://doi.org/10.1016/j.urolonc.2005.06.016

@article{c49f80ac0148454fa842043b0c823683,

title = "Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer",

author = "Galsky, {M. D.} and Small, {E. J.} and Oh, {W. K.} and I. Chen and Smith, {D. C.} and Colevas, {A. D.} and L. Martone and T. Curley and A. Delacruz and Scher, {H. I.} and Kelly, {W. K.} and Trump, {Donald L.}",

year = "2005",

doi = "10.1016/j.urolonc.2005.06.016",

language = "English",

volume = "23",

pages = "378",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

Galsky, MD, Small, EJ, Oh, WK, Chen, I, Smith, DC, Colevas, AD, Martone, L, Curley, T, Delacruz, A, Scher, HI, Kelly, WK & Trump, DL 2005, 'Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer', Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 5, pp. 378. https://doi.org/10.1016/j.urolonc.2005.06.016

Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer. / Galsky, M. D.; Small, E. J.; Oh, W. K. et al.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 23, No. 5, 2005, p. 378.

Research output: Contribution to journal › Short survey › peer-review

TY - JOUR

T1 - Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer

AU - Galsky, M. D.

AU - Small, E. J.

AU - Oh, W. K.

AU - Chen, I.

AU - Smith, D. C.

AU - Colevas, A. D.

AU - Martone, L.

AU - Curley, T.

AU - Delacruz, A.

AU - Scher, H. I.

AU - Kelly, W. K.

AU - Trump, Donald L.

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=24344457663&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2005.06.016

DO - 10.1016/j.urolonc.2005.06.016

M3 - Short survey

AN - SCOPUS:24344457663

SN - 1078-1439

VL - 23

SP - 378

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

Galsky MD, Small EJ, Oh WK, Chen I, Smith DC, Colevas AD et al. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer. Urologic Oncology: Seminars and Original Investigations. 2005;23(5):378. doi: 10.1016/j.urolonc.2005.06.016